Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities by Kay K. Myo Min, Charlie B. Ffrench, Claire F. Jessup, Mia Shepherdson, Savio George Barreto, Claudine S. Bonder

Get full text

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma by Lisa M. Ebert, Kate Vandyke, M. Zahied Johan, Mark DeNichilo, Lih Y. Tan, Kay K. Myo Min, Benjamin M. Weimann, Brenton W. Ebert, Stuart M. Pitson, Andrew C. W. Zannettino, Craig T. Wallington‐Beddoe, Claudine S. Bonder

Get full text

Desmoglein-2 as a cancer modulator: friend or foe? by Kay K. Myo Min, Charlie B. Ffrench, Barbara J. McClure, Barbara J. McClure, Michael Ortiz, Emma L. Dorward, Michael S. Samuel, Michael S. Samuel, Michael S. Samuel, Lisa M. Ebert, Lisa M. Ebert, Mỹ G. Mahoney, Claudine S. Bonder, Claudine S. Bonder

Get full text

Desmoglein-2 is important for islet function and β-cell survival by Kay K. Myo Min, Darling Rojas-Canales, Daniella Penko, Mark DeNichilo, Michaelia P. Cockshell, Charlie B. Ffrench, Emma J. Thompson, Olof Asplund, Christopher J. Drogemuller, Rashmi B. Prasad, Leif Groop, Shane T. Grey, Helen E. Thomas, Thomas Loudovaris, Thomas W. Kay, My G. Mahoney, Claire F. Jessup, P. Toby Coates, Claudine S. Bonder

Get full text